Public Health Strategies Contain and Mitigate COVID-19: A Tale of Two Democracies - 26/11/20
Funding: None. |
|
Conflict of Interest: CHH reports that he serves as an independent scientist in an advisory role to investigators and sponsors as chair of data monitoring committees for Amgen, British Heart Foundation, Cadila, Canadian Institutes of Health Research, DalCor, and Regeneron, and to the Collaborative Institutional Training Initiative (CITI), legal counsel for Pfizer, the United States Food and Drug Administration, and UpToDate; receives royalties for authorship or editorship of 3 textbooks and as co-inventor on patents for inflammatory markers and cardiovascular disease that are held by Brigham and Women's Hospital; has an investment management relationship with the West-Bacon Group within SunTrust Investment Services, which has discretionary investment authority; does not own any common or preferred stock in any pharmaceutical or medical device company. JJS, DGM, TAA, and RDS have no disclosures. |
|
Authorship: All authors had access to the data and a role in writing this manuscript. |
Vol 133 - N° 12
P. 1365-1366 - décembre 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.